Biolight Life Sciences Ltd. (BOLT)
TASE
Closed
Aug 25, 2026
Day's Range
264.6052 wk Range
5.19Overview - BOLT - Biolight Life Sciences Ltd.
Key Statistics
Valuation
Enterprise Value
2.45B
P/E (Trailing)
‪-140.90‬
Price / Book
‪69.57‬
EV / EBITDA
‪-0.46‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-24.83%‬
Return on Equity
‪-48.41%‬
Ownership
Shares Outstanding
9.04M
Float
5.22M
Held by Insiders
‪54.50%‬
Held by Institutions
‪7.09%‬
Price stats
Beta
‪0.61‬
50-Day Avg
‪363.26‬
200-Day Avg
‪333.78‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BOLT - Biolight Life Sciences Ltd.
Peers - BOLT - Biolight Life Sciences Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on TASE.
Profile Summary - BOLT - Biolight Life Sciences Ltd.
About
Biolight Life Sciences Ltd. is a dynamic player in the biotechnology sector, focused on developing and commercializing cutting-edge medical technology products. The company's primary function is to innovate within the healthcare field, aiming to improve patient outcomes and enhance the accuracy of medical diagnostics.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
